Triamterene crystalline nephropathy

Am J Kidney Dis. 2014 Jan;63(1):148-52. doi: 10.1053/j.ajkd.2013.06.023. Epub 2013 Aug 16.

Abstract

Medications can cause a tubulointerstitial insult leading to acute kidney injury through multiple mechanisms. Acute tubular injury, a dose-dependent process, occurs due to direct toxicity on tubular cells. Acute interstitial nephritis characterized by interstitial inflammation and tubulitis develops from drugs that incite an allergic reaction. Other less common mechanisms include osmotic nephrosis and crystalline nephropathy. The latter complication is rare but has been associated with several drugs, such as sulfadiazine, indinavir, methotrexate, and ciprofloxacin. Triamterene crystalline nephropathy has been reported only rarely, and its histologic characteristics are not well characterized. We report 2 cases of triamterene crystalline nephropathy, one of which initially was misdiagnosed as 2,8-dihydroxyadenine crystalline nephropathy.

Keywords: Triamterene; acute kidney injury; crystalline nephropathy; drug nephrotoxicity; kidney biopsy.

Publication types

  • Case Reports

MeSH terms

  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / adverse effects
  • Biopsy
  • Creatinine / blood
  • Diagnostic Errors / prevention & control
  • Drug Combinations
  • Drug-Related Side Effects and Adverse Reactions / diagnosis
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Female
  • Fluorescent Antibody Technique
  • Glomerular Filtration Rate
  • Humans
  • Hydrochlorothiazide / administration & dosage
  • Hydrochlorothiazide / adverse effects*
  • Kidney / pathology*
  • Liddle Syndrome / drug therapy
  • Meniere Disease / drug therapy
  • Middle Aged
  • Renal Insufficiency, Chronic* / chemically induced
  • Renal Insufficiency, Chronic* / pathology
  • Renal Insufficiency, Chronic* / physiopathology
  • Renal Insufficiency, Chronic* / therapy
  • Treatment Outcome
  • Triamterene / administration & dosage
  • Triamterene / adverse effects*
  • Withholding Treatment*

Substances

  • Antihypertensive Agents
  • Drug Combinations
  • Hydrochlorothiazide
  • hydrochlorothiazide-triamterene
  • Creatinine
  • Triamterene